BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ziltivekimab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Ziltivekimab\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06118281-606@assetmemo.bio
DTSTAMP:20261121T005233Z
DTSTART;VALUE=DATE:20270129
DTEND;VALUE=DATE:20270130
SUMMARY:Ziltivekimab: Phase 3 readout est. (NCT06118281)
DESCRIPTION:Ziltivekimab\, phase 3.\nStudy: ARTEMIS - A Research Study to L
 ook at How Ziltivekimab Works Compared to Placebo in People With a Heart A
 ttack\nEstimated primary completion: 29 January 2027. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/ziltivekimab#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT06118281
URL:https://assetmemo.bio/drug/ziltivekimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07276282-606@assetmemo.bio
DTSTAMP:20261121T005233Z
DTSTART;VALUE=DATE:20280901
DTEND;VALUE=DATE:20280902
SUMMARY:Ziltivekimab: Phase 3 readout est. (NCT07276282)
DESCRIPTION:Ziltivekimab\, phase 3\, Atherosclerotic Cardiovascular Disease
 .\nStudy: Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Pa
 tients With Acute Myocardial Infarction\nEstimated primary completion: 1 S
 eptember 2028. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ziltiv
 ekimab#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07276282
URL:https://assetmemo.bio/drug/ziltivekimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07301034-606@assetmemo.bio
DTSTAMP:20261121T005233Z
DTSTART;VALUE=DATE:20281114
DTEND;VALUE=DATE:20281115
SUMMARY:Ziltivekimab: Phase 3 readout est. (NCT07301034)
DESCRIPTION:Ziltivekimab\, phase 3.\nStudy: A Research Study to Look at the
  Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart\, Comp
 ared to Placebo\, in People With a Heart Attack\nEstimated primary complet
 ion: 14 November 2028. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/ziltivekimab#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07301034
URL:https://assetmemo.bio/drug/ziltivekimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
